Concepedia

K. Panageas

KP

Statistics

Publications

20

Citations

2K

H-Index

19

Active since

1998

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Northwestern University

University of California, San Francisco

Chapman University

K. Panageas is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, medicine, and neuro-oncology.

Publications per year

1998–2013

20

Publications

20

Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome

Patrick G. Morris, Denise D. Correa, Joachim Yahalom et al. · Journal of Clinical Oncology · 2013 · 491 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients.

Victor R. Grann, K. Panageas, William Whang et al. · Journal of Clinical Oncology · 1998 · 208 citations

Medicine, Oncology, Surgery +17

Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21.

Teresa Gilewski, Sucharita Adluri, Govind Ragupathi et al. · PubMed · 2000 · 204 citations

Medicine, Immunology, Oncology +17

When You Look Matters: The Effect of Assessment Schedule on Progression-Free Survival

K. Panageas, Leah Ben‐Porat, Maura N. Dickler et al. · JNCI Journal of the National Cancer Institute · 2007 · 174 citations · Full text

Medicine, Oncology, Radiology +17

Evaluation of serum IL-17 levels during ipilimumab therapy: Correlation with colitis.

Margaret K. Callahan, Aili Yang, S Tandon et al. · Journal of Clinical Oncology · 2011 · 132 citations

Veterinary Medicine, Immunology, Pharmacotherapy +17

1–5 of 20